Cargando…

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model

BACKGROUND: The bactericidal activity of an antimicrobial drug is generally assessed by in vitro bacterial time-kill experiments which do not include any components of the immune system, even though the innate immunity, the primary host defence, is probably able to kill a large proportion of pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lallemand, Elodie Anne, Zemirline, Claudine, Toutain, Pierre-Louis, Bousquet-Melou, Alain, Ferran, Aude A., Boullier, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792187/ https://www.ncbi.nlm.nih.gov/pubmed/33413376 http://dx.doi.org/10.1186/s12917-021-02746-8

Ejemplares similares

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model
por: Broussou, Diane C., et al.
Publicado: (2018)

Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate
por: Liu, JingJing, et al.
Publicado: (2021)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses
por: Lallemand, Elodie A., et al.
Publicado: (2023)

Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis
por: Okumura, Nobumasa, et al.
Publicado: (2023)

High Bioavailability of Bisphenol A from Sublingual Exposure
por: Gayrard, Véronique, et al.
Publicado: (2013)

Interpreting Bisphenol A Absorption in the Canine Oral Cavity: Gayrard et al. Respond
por: Gayrard, Véronique, et al.
Publicado: (2013)

Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives
por: Lhermie, Guillaume, et al.
Publicado: (2017)

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
por: Bousquet-Mélou, Alain, et al.
Publicado: (2021)

Effects of Growth Medium and Inoculum Size on Pharmacodynamics Activity of Marbofloxacin against Staphylococcus aureus Isolated from Caprine Clinical Mastitis
por: Lorenzutti, Augusto Matías, et al.
Publicado: (2021)

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Miller, William R, et al.
Publicado: (2018)

Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections
por: Haynes, Andrew S., et al.
Publicado: (2022)

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination
por: Ferran, Aude A., et al.
Publicado: (2020)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Cephalexin: clinical and laboratory studies.
por: Lyons, R. W., et al.
Publicado: (1971)

Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014)

Cephalexin-Induced Leukocytoclastic Vasculitis
por: Tang, Wesley, et al.
Publicado: (2022)

852. The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does It Matter?
por: McNeil, Jonathan C, et al.
Publicado: (2019)

Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes”
por: Gayrard, Véronique, et al.
Publicado: (2015)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, D., et al.
Publicado: (2019)

Transcriptomic analysis of milk somatic cells in mastitis resistant and susceptible sheep upon challenge with Staphylococcus epidermidis and Staphylococcus aureus
por: Bonnefont, Cécile MD, et al.
Publicado: (2011)

Cephalexin-induced acute generalized exanthematous pustulosis
por: DaCunha, Matthew, et al.
Publicado: (2018)

1506. Outcomes of Standardized Neonatal Cephalexin Dosing
por: Robertson, Melena J, et al.
Publicado: (2019)

2063. Extracellular Release of β-Lactamase Is Responsible for the Cefazolin Inoculum Effect (CzIE) in Methicillin-Susceptible Staphylococcus aureus
por: Carvajal, Lina P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fjmcu19ba8ovikjp2imh81b4o3